Research Analysis Reports EPO Biosimilars - The Future of Erythropoietin Mar | Page 2

In addition, the report provides insight about the major drivers and challenges, along with the latest
trends and developments impacting the industry growth.
Request A Sample Copy of This Report at:
http://www.radiantinsights.com/research/epo-biosimilars-the-future-of-erythropoietin-
market/request-sample
The global erythropoietin market has been segmented into biologic and biosimilar erythropoietin
markets. The report also highlights the various biologic and biosimilar erythropoietin drugs currently
available in the market. Furthermore, the global erythropoietin market has also been segmented on
the basis of their applications. Based on geography, the report divides the market into the US,
Europe, and Asia-Pacific.
The last section of the report discusses about the prominent players in global erythropoietin market.
Market share analysis of these players is also provided in the report. A brief business overview and
financial information about each of these players has been provided along with their product
portfolios. The recent development of every player has also been presented in the report. Overall,
the research contains exhaustive information that will help clients in formulating market strategies
and assessing opportunity areas in the global erythropoietin market.
Table of Contents:
1. Analyst View
2. Research Methodology
3. Industry Trends and Drivers
4. Industry Challenges
5. Global Protein Therapeutics Market
6. Erythropoietin Market - Introduction
7. Global Erythropoietin Market Outlook to 2022
8. Market Segmentation
9. Global Erythropoietin Market by Geography
10. Pipeline Analysis of Erythropoietin
11. Competitive Landscape
List of Tables:





Table
Table
Table
Table
Table
Follow Us:
8-1: Global - Biologic Erythropoietin Drugs and Their Sales
10-1: Global - Erythropoietin Product Pipeline
11-1: Amgen Inc. - Total Company Revenue (Billion US$), 2013, 2014 & 2015
11-2: Amgen Inc. - Commercialized Erythropoietin Products
11-3: Amgen Inc. - Erythropoietin Product Sales (Billion US$), 2013, 2014 & 2015